Please use this identifier to cite or link to this item:
http://hdl.handle.net/2067/42807
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Fanelli, Giuseppina | it |
dc.contributor.author | Belardo, Antonio | it |
dc.contributor.author | Savino, Rocco | it |
dc.contributor.author | Rinalducci, Sara | it |
dc.contributor.author | Zolla, Lello | it |
dc.date.accessioned | 2021-02-13T22:48:51Z | - |
dc.date.available | 2021-02-13T22:48:51Z | - |
dc.date.issued | 2020 | it |
dc.identifier.issn | 1582-1838 | it |
dc.identifier.uri | http://hdl.handle.net/2067/42807 | - |
dc.description.abstract | Male hypogonadism is notoriously associated with altered lipid metabolism. In this study, we performed an untargeted mass spectrometry-based profiling of plasma lipids from twenty healthy and twenty hypogonadal men before and after testosterone replacement therapy (TRT) for 60 days. Results demonstrated that hypogonadism was associated with a significant increase in sphingomyelin (SM), whereas phosphatidylcholine (PC) was mainly cleaved by activated phospholipase-A2 into lysophosphatidylcholine (LPC). In hypogonadal patients, arachidonic acid (AA), also produced through the latter cleavage, was prevalently bio-transformed into leukotriene B4 (LTB4) and not into endoperoxides from which prostaglandins and thromboxanes are derived. Interestingly, upon testosterone treatment SM, PC and LPC returned to levels similar to controls. Also, AA was newly converted into prostaglandin-A2, thromboxane-A2 and 5(S)-hydroxyeicosatetraenoic acid (HETE), suggesting that testosterone probably plays a role in controlling hypogonadal alterations above reported. | it |
dc.language.iso | eng | it |
dc.rights | Attribution 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.title | Testosterone replacement therapy in insulin-sensitive hypogonadal men restores phosphatidylcholine levels by regulation of arachidonic acid metabolism | it |
dc.type | article | * |
dc.identifier.doi | 10.1111/jcmm.15392 | it |
dc.identifier.pmid | 32491269 | it |
dc.identifier.scopus | 2-s2.0-85085887447 | it |
dc.identifier.url | https://onlinelibrary.wiley.com/doi/full/10.1111/jcmm.15392 | it |
dc.relation.journal | JOURNAL OF CELLULAR AND MOLECULAR MEDICINE | it |
dc.relation.firstpage | 8266 | it |
dc.relation.lastpage | 8269 | it |
dc.relation.volume | 24 | it |
dc.relation.issue | 14 | it |
dc.description.international | no | it |
dc.contributor.country | ITA | it |
dc.type.referee | REF_1 | it |
dc.type.miur | 262 | * |
item.fulltext | With Fulltext | - |
item.openairetype | article | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | restricted | - |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
crisitem.journal.journalissn | 1582-1838 | - |
crisitem.journal.ance | E184185 | - |
Appears in Collections: | A1. Articolo in rivista |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
J Cell Mol Med 2020_hypogonadism.pdf | 459.74 kB | Adobe PDF | View/Open |
SCOPUSTM
Citations
20
9
Last Week
0
0
Last month
0
0
checked on Mar 22, 2024
Page view(s)
112
Last Week
1
1
Last month
1
1
checked on Mar 27, 2024
Download(s)
20
checked on Mar 27, 2024
Google ScholarTM
Check
Altmetric
This item is licensed under a Creative Commons License